Ignite Creation Date:
2024-05-06 @ 3:50 AM
Last Modification Date:
2024-10-26 @ 11:39 AM
Study NCT ID:
NCT02389244
Status:
RECRUITING
Last Update Posted:
2023-11-07
First Post:
2015-02-09
Brief Title:
A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas
Sponsor:
UNICANCER
Organization:
UNICANCER
Organization Data
Organization:
UNICANCER
Class:
OTHER
Study ID:
UC-01501309
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UNICANCER
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None